AbCellera Collaborates with Autolus on Antibody Discovery Project

06:08 EST 29 Nov 2018 | Businesswire
This article has expired, however you can still download the PDF.
AbCellera’s antibody discovery engine will isolate novel antibodies for the development of targeted CAR-T cell therapy AbCellera announced today its collaboration with Autolus Therapeutics plc (Autolus), a clinical ...

Other Sources for this Article

Kevin Heyries, PhD
Telephone: 604.559.9005


More From BioPortfolio on "AbCellera Collaborates with Autolus on Antibody Discovery Project"

Quick Search

Relevant Topics

An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...